Open AccessOmalizumab-A review
Author(s) -
Kiran Godse,
Aayushi Mehta,
Sharmila Patil,
Manjyot Gautam,
Nitin Nadkarni
Publication year - 2015
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/0019-5154.160490
Subject(s) - omalizumab , medicine , immunoglobulin e , monoclonal antibody , recombinant dna , antibody , monoclonal , chronic urticaria , immunology , biochemistry , chemistry , gene
Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE). The US FDA has approved this molecule for chronic urticaria.